Evaluation of different scaffolds for BMP‐2 genetic orthopedic tissue engineering
- 15 July 2005
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 75B (2) , 289-303
Abstract
To better understand the effects of scaffold materials for bone morphogenetic protein 2 (BMP‐2) genetic tissue engineering in vivo, several gels, including alginate, collagen, agarose, hyaluronate, fibrin, or Pluronic, were mixed with adenovirus‐mediated human BMP‐2 gene (Adv‐hBMP‐2) transduced bone marrow stromal cells (BMSCs) and injected into the muscles of athymic mice to evaluate the resulting osteogenesis and chondrogenesis. These gel and gene‐transduced BMSC mixtures were also loaded onto β‐TCP/HAP biphasic calcined bone (BCB) and observed under scanning electron microscopy (SEM). In addition, these composite scaffolds were implanted into the subcutaneous site of athymic mice to construct tissue‐engineered bone. After injection, collagen, hyaluronate, or alginate gel mixed with gene‐transduced BMSCs induced more bone formation than a cell suspension in α‐MEM. The agarose‐gene‐transduced BMSC gel was found to contain much more hyaline cartilage. SEM showed the BMSCs could survive in alginate, agarose, and collagen gel in vitro for up to 8 d. After implantation of tissue‐engineered bone, the alginate, collagen, and agarose gel could promote new bone formation within a BCB in vivo. Little or no bone formed after injection of fibrin or Pluronic gel mixed with BMSCs or implantation with BCB. These findings help to elucidate the effects of various scaffold materials for future research in orthopedic tissue engineering using BMP‐2 transduced cells. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2005Keywords
This publication has 36 references indexed in Scilit:
- Regulating Bone Formation via Controlled Scaffold DegradationJournal of Dental Research, 2003
- Cell‐based bonding of articular cartilage: An extended studyJournal of Biomedical Materials Research Part A, 2003
- Gene Therapy of Bone Morphogenetic Protein for Periodontal Tissue EngineeringJournal of Periodontology, 2003
- Treatment of Osteochondral Defects with Autologous Bone Marrow in a Hyaluronan-Based Delivery VehicleTissue Engineering, 2002
- Stimulation of Smad1 Transcriptional Activity by Ras-Extracellular Signal-Regulated Kinase Pathway: A Possible Mechanism for Collagen-Dependent Osteoblastic DifferentiationJournal of Bone and Mineral Research, 2002
- Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destructionArthritis & Rheumatism, 2002
- Degradation of Partially Oxidized Alginate and Its Potential Application for Tissue EngineeringBiotechnology Progress, 2001
- Tissue-Engineered Fabrication of an Osteochondral Composite Graft Using Rat Bone Marrow-Derived Mesenchymal Stem CellsTissue Engineering, 2001
- Cellular Immune Responses of Healthy Individuals to Intradermal Administration of an E1 - E3 - Adenovirus Gene Transfer VectorHuman Gene Therapy, 1999
- Biosynthetic Bone GraftingClinical Orthopaedics and Related Research, 1999